Twenty-eight patients with suspected or known steno-occlusive disease of the carotid ( n = @ ) , renal ( n = @ ) or peripheral arteries ( n = @ ) were randomised to receive either @ mmol/kg gadobenate dimeglumine or @ mmol/kg gadopentetate dimeglumine for a first CE-MRA procedure .